Oriola-KD to join forces with KF on the Swedish pharmacy market
Oriola-KD and KF (Kooperativa Förbundet) have agreed to join forces on the Swedish pharmacy market, which will be deregulated on 1 July 2009. The cooperation comprises of preparation for the divestment process of Apoteket AB's pharmacy clusters and the establishment of new pharmacies, mainly in conjunction with Coop's hyper and supermarkets owned by KF. The target of Oriola-KD and KF is to establish a joint venture, in which Oriola-KD would hold the majority ownership and be responsible for the development and management of the pharmacy chain.
A precondition for the establishment of the joint venture is the acquisition of a sufficient number of pharmacies in the pharmacy cluster divestment process, which would make the creation of a significant new pharmacy chain possible.
After the deregulation of the Swedish pharmacy market, also other actors than Apoteket AB are allowed to run pharmacies. In conjunction with the deregulation, 466 pharmacies will be sold to large and midsize companies and around 150 of the pharmacies remaining in state ownership will be sold to entrepreneurs and small business owners in a separate process. Apoteket AB will retain 330 pharmacies. There are currently some 946 pharmacies in Sweden.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
MDxHealth Appoints New Scientific Advisory Board
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

Eppendorf opens new site in Singapore - Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services

Key role found for enzymes in DNA replication and sensitivity to chemotherapeutic drugs
GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences - Global alliance in biomolecular imaging

"Census" in the zebrafish's brain - Scientists explore newborn, regenerated neurons
